Positioning Taiwan as an Asia-Pacific Biomedical R&D Hub – Is Taiwan Ready for the Top Spot?” That provocative topic was the theme of a half-day conference – held April 25 at the Chang Yung-Fa Foundation’s International Convention Center – that featured a number of prominent expert speakers and panelists from both Taiwan and internationally. The…

Corporate Social Responsibility (CSR) i s an extremely important part of Pfizer’s vision and mission of “Working Together for a Healthier World.” For many years, the company has been involved in programs around the world to help advance healthcare and public health causes, including collaboration with the World Health Organization (WHO) and non-profit organizations such…

Taiwan has one of the world’s most efficient, accessible, and effective healthcare systems, offering quality care at affordable prices. Yet despite this success, the rapid aging of Taiwan’s population is presenting an unprecedented challenge to Taiwan’s National Health Insurance (NHI) system. According to the National Development Council, this year 14% of Taiwan’s population will be…

Finding new treatments for difficult to cure diseases Devoted to improving local education and medical care Although Chicago-based AbbVie was founded only five years ago, its performance in delivering new drugs for hard-to-treat diseases and its dedication to improving local medical services and education have quickly received global attention. “Our goal is to provide groundbreaking…

At long last, the much anticipated Taoyuan Aerotropolis project is ready for take-off. The Aerotropolis is a planned transportation, logistics, industrial, and residential city encompassing the existing Taiwan Taoyuan International Airport.  With a footprint of over 4,500 hectares, the Aerotropolis will be one of Taiwan’s largest national infrastructure projects ever. Originally conceived years ago as…

The Taiwan government deserves congratulations for its recent enactment of landmark legislation establishing a Patent Linkage system for pharmaceutical products, a mechanism designed to prevent infringing drugs from being licensed while an original medication still holds a valid patent in this market. Credit goes both to the executive branch agencies that ushered through this initiative…